Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol versus dinoprostone for cervical ripening in primiparous women
ACTRN12616000522415Phase 4Terminated
- Sponsor
- John Hunter Hospital
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cervical ripening (CR) comparing Misoprostol pessary with Dinoprostone pessary (2 arms). Primary endpoints: Need for further cervical ripening with balloon, Need for oxytocin induction and 1 more. Started Oct 2015; status: terminated.
02
Drugs
misoprostoldinoprostone
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on ACTRN12616000522415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000522415.